Gilead coronavirus drug

Vials of investigational coronavirus disease (Covid-19) treatment drug remdesivir are capped at a Gilead Sciences facility in La Verne, California, US March 18, 2020. Gilead Sciences Inc/Handout via Reuters
Coronavirus chronicle

US to allow states to distribute Gilead's remdesivir to fight Covid-19

Gilead’s drug has shown promise in helping patients infected with Covid-19, the illness caused by the novel coronavirus, and is being closely watched on how the limited supply is distributed

FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (Covid-19), during the outbreak of the coronavirus disease (Covid-19), in Oceanside, California, US, April 29, 2020. REUTERS/Mike Blake/
Coronavirus chronicle

Will Gilead price its coronavirus drug for public good or company profit?

Photo: Collected
Coronavirus chronicle

Gilead Sciences exporting remdesivir, CEO says

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters
Coronavirus chronicle

Explainer: What does new data say about Gilead's experimental coronavirus drug?

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters
Coronavirus chronicle

Trial of Gilead's potential coronavirus treatment running ahead of schedule, researcher says

In this photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States.AP Photo
Coronavirus chronicle

1st results in on Gilead coronavirus drug; more study needed